Medical Weight Loss in Miami: Semaglutide, Tirzepatide & GLP-1

More than one in four adults in Florida lives with obesity — and in Miami-Dade County, the cultural pressure to "just eat less and move more" collides daily with the biological reality that weight is far more complex than willpower. If you have tried diets, calorie-counting apps, and gym memberships only to regain everything you lost, you are not failing. Your hormones, your gut, and your genetics are working against you — and modern medicine finally has tools powerful enough to work with your biology instead of against it.

Medical weight loss programs, anchored by a new class of medications called GLP-1 receptor agonists — including semaglutide (Ozempic / Wegovy) and tirzepatide (Mounjaro / Zepbound) — are producing results that were unthinkable a decade ago. At Viva Medical Center in Doral, FL, our board-certified physicians supervise these programs every day, helping patients achieve lasting, medically meaningful weight loss. We serve patients in English and Spanish.

Why Medical Weight Loss Is Different From Dieting

A conventional diet works on a simple premise: eat less, burn more. And for a few weeks, it often works. But the body interprets sustained caloric restriction as famine. It responds by lowering your resting metabolic rate, increasing hunger hormones like ghrelin, and reducing satiety signals. This is not a character flaw — it is an evolutionary survival mechanism that has kept humans alive for hundreds of thousands of years.

Research published in the New England Journal of Medicine and other peer-reviewed journals confirms that after significant weight loss, the body's hormonal environment shifts dramatically in favor of regain. Levels of leptin (the "fullness" hormone) drop, while appetite-stimulating hormones surge — sometimes for years after the diet ends. This is why most people who lose weight through diet alone regain 50–80% of it within two years.

Medical weight loss is different because it addresses these root causes. A physician evaluates your metabolic health — thyroid function, insulin resistance, cortisol levels, lipid profile — and designs a protocol that resets the hormonal environment driving weight gain. Medications, lifestyle coaching, and regular clinical monitoring work together to produce sustainable results that dieting alone cannot achieve.

How GLP-1 Medications Work: Semaglutide and Tirzepatide Explained

GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the gut after you eat. It tells your pancreas to release insulin, signals your brain that you are full, and slows gastric emptying so food stays in your stomach longer. In people with obesity, this signaling system is often blunted — the brain does not receive a strong enough "I'm satisfied" message, leading to persistent overeating.

GLP-1 receptor agonists mimic and amplify this natural hormone. They bind to GLP-1 receptors in the brain's hypothalamus, the pancreas, and the gastrointestinal tract — simultaneously reducing appetite, improving blood sugar control, and slowing the rate at which the stomach empties. The result is that patients feel full on significantly less food, without the white-knuckle hunger that derails every conventional diet.

Semaglutide (the active ingredient in Ozempic and Wegovy) is a pure GLP-1 receptor agonist. In the landmark SELECT trial — a large, randomized, placebo-controlled study of 17,604 adults with obesity and cardiovascular disease — semaglutide 2.4 mg produced an average weight reduction of 10.2% of body weight sustained over four years. Critically, SELECT also showed a 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) compared to placebo, confirming that the benefits go far beyond the scale.

Tirzepatide (Mounjaro / Zepbound) is a dual-action molecule — a GIP and GLP-1 receptor agonist — that activates two complementary hormonal pathways simultaneously, producing even greater appetite suppression and metabolic improvement. In the SURMOUNT-1 trial, adults with obesity taking tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks — roughly 52 pounds for a 230-pound individual. Separately, the 2025 SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine confirmed that tirzepatide produced 20.2% average weight loss versus 13.7% for semaglutide — a statistically significant advantage. Nearly 20% of tirzepatide patients achieved 30% or greater body weight reduction.

Semaglutide vs. Tirzepatide: Which Is Right for You?

Both medications are highly effective, FDA-approved for chronic weight management, and administered as once-weekly subcutaneous injections. The right choice depends on your medical history, comorbidities, and individual response. This is not medical advice — always consult your physician before starting any medication.

• Semaglutide (Wegovy / Ozempic): Average weight loss of 10–15%. Backed by the most long-term cardiovascular outcome data (SELECT trial). Available as Wegovy (weight management) or Ozempic (diabetes). Starting dose 0.25 mg weekly, titrated over 16–20 weeks to 2.4 mg. Common side effects: nausea, vomiting, diarrhea, constipation — usually mild to moderate and improve after the titration period. Generally well-tolerated. Insurance coverage for Wegovy is growing as cardiovascular indications are approved.
• Tirzepatide (Zepbound / Mounjaro): Average weight loss of 20–22.5%. Superior results in head-to-head comparison with semaglutide (SURMOUNT-5). Starting dose 2.5 mg weekly, titrated to 5, 7.5, 10, 12.5, or 15 mg. Side effect profile similar to semaglutide. May be preferred for patients with type 2 diabetes or significant insulin resistance due to dual GIP/GLP-1 action. Zepbound is increasingly covered by insurance with prior authorization.
• Cost considerations: Both medications can exceed $1,000/month without insurance. Your physician can assist with manufacturer savings programs (Lilly Savings Card, Novo Nordisk patient assistance) and insurance prior authorization. Generic and compounded versions have been available but regulatory status is evolving — your doctor will advise on current approved options.
• Who is a good candidate: BMI ≥30, or BMI ≥27 with at least one weight-related condition (type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea). Not appropriate during pregnancy or for patients with a personal/family history of medullary thyroid carcinoma or MEN2.

What to Expect from a Medical Weight Loss Program in Miami

Starting a GLP-1 program at a primary care office in Miami is a medically supervised process — not a vending machine transaction. Here is what a comprehensive program looks like:

• Initial evaluation: A full medical history and physical exam to assess candidacy, existing conditions, and contraindications. Your physician reviews your previous weight loss attempts, medications, and goals.
• Lab work: Baseline labs typically include HbA1c (blood sugar), fasting lipid panel, thyroid function (TSH, free T4), comprehensive metabolic panel, and in some cases vitamin B12 and D levels. This establishes your metabolic baseline and rules out thyroid-related causes of weight gain.
• Medication initiation and titration: GLP-1 medications are started at the lowest dose and increased slowly — usually every 4 weeks — to minimize gastrointestinal side effects and find your optimal therapeutic dose. Your physician guides every step.
• Monthly follow-ups: Weight, blood pressure, heart rate, and lab values are monitored regularly. Your physician adjusts the dose, addresses side effects, and tracks progress against your goals.
• Lifestyle coaching: Medication works best alongside sustainable dietary changes and physical activity. Your care team provides practical guidance on nutrition and movement — not a punishing regimen, but a realistic and enjoyable approach to living well.

Expect meaningful weight loss within the first 4–8 weeks. Most patients lose 5–10% of body weight in the first 3 months, with continued loss over 12–18 months. The goal is not just a lower number on the scale — it is improved blood sugar, lower blood pressure, better sleep, and more energy for the life you want to live.

Start Your Weight Loss Journey at Viva Medical Center in Doral, FL

You do not need to keep fighting your biology alone. At Viva Medical Center in Doral, FL, our board-certified primary care physicians combine the latest GLP-1 therapies with personalized clinical care, lab monitoring, and lifestyle support — all under one roof. Whether you are exploring semaglutide, tirzepatide, or simply want to understand your options, we are here to give you honest, science-based guidance without judgment.

We are proud to serve our diverse Miami community in both English and Spanish. From your first consultation to your ongoing monthly visits, you will have a physician — not a weight loss "coach" — guiding your care every step of the way.

Ready to find out if medical weight loss is right for you? Call us today at +1 305 209 0001 or visit our Weight Loss & Wellness page to learn more and request your appointment. Your healthiest self is not a destination — it is a journey worth starting now.